MREC Reviewer Comment
Protocol Title
Insights into predicting hepatocellular carcinoma in cirrhotic DAA-response/failure HCV-Egyptian patients using circulating HCV core antigen, CD163, IL-10/12 levels and Claudin-1/TGF-β1 expression profiles, and their prognostic capacity of immunotherapy outcome in HCV-related HCC patients.
Completely satisfied and informative data
Needs Explanation
Comments to the applicant
Non
Comment to the Committee
- Please correct the Study Type: from Interventional Studies to retrospective case-control
- Please elaborate on the collection and storage of blood sample sites and the ethical situation of the samples are their broad consent for use in future research?
Informed consent form:
N/A
